Adler, LE, Pachtman, E, Franks, RD, Pecevich, M, Waldo, MC, Freedman, R (1982). Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biological Psychiatry 17, 639–654.
Altar, CA, Cai, N, Bliven, T, Juhasz, M, Conner, JM, Acheson, AL, Lindsay, RM, Wiegand, SJ (1997). Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389, 856–860.
Baker, N, Staunton, M, Adler, L, Gerhardt, G, Drebing, C, Waldo, M, Nagamoto, H, Freedman, R (1990). Sensory gating deficits in psychiatric inpatients: relation to catecholamine metabolites in different diagnostic groups. Biological Psychiatry 27, 519–528.
Blackwood, DH, Fordyce, A, Walker, MT, St Clair, DM, Porteous, DJ, Muir, WJ (2001). Schizophrenia and affective disorders – cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. American Journal of Human Genetics 69, 428–433.
Braff, DL, Freedman, R, Schork, NJ, Gottesman, II (2007). Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophrenia Bulletin 33, 21–32.
Bramon, E, Dempster, E, Frangou, S, McDonald, C, Schoenberg, P, MacCabe, JH, Walshe, M, Sham, P, Collier, D, Murray, RM (2006). Is there an association between the COMT gene and P300 endophenotypes? European Psychiatry 21, 70–73.
Bramon, E, Dempster, E, Frangou, S, Shaikh, M, Walshe, M, Filbey, FM, McDonald, C, Sham, P, Collier, DA, Murray, R (2008). Neuregulin-1 and the P300 waveform – a preliminary association study using a psychosis endophenotype. Schizophrenia Research 103, 178–185.
Cannon, TD, Keller, MC (2006). Endophenotypes in the genetic analyses of mental disorders. Annual Review of Clinical Psychology 2, 267–290.
Chen, QY, Chen, Q, Feng, GY, Wan, CL, Lindpaintner, K, Wang, LJ, Chen, ZX, Gao, ZS, Tang, JS, Li, XW, He, L (2006). Association between the brain-derived neurotrophic factor (BDNF) gene and schizophrenia in the Chinese population. Neuroscience Letters 397, 285–290.
Chen, YJ, Johnson, MA, Lieberman, MD, Goodchild, RE, Schobel, S, Lewandowski, N, Rosoklija, G, Liu, RC, Gingrich, JA, Small, S, Moore, H, Dwork, AJ, Talmage, DA, Role, LW (2008). Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. Journal of Neuroscience 28, 6872–6883.
Chen, ZY, Patel, PD, Sant, G, Meng, CX, Teng, KK, Hempstead, BL, Lee, FS (2004). Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. Journal of Neuroscience 24, 4401–4411.
Clementz, B, Geyer, M, Braff, D (1998 a). Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. American Journal of Psychiatry 155, 1691–1694.
Clementz, BA, Geyer, MA, Braff, DL (1997). P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis. Biological Psychiatry 41, 1035–1044.
Clementz, BA, Geyer, MA, Braff, DL (1998 b). Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophrenia Research 30, 71–80.
Cohen, J (1969). Statistical Power Analysis for the Behavioral Sciences. Academic Press: New York.
Corfas, G, Roy, K, Buxbaum, J (2004). Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nature Neuroscience 7, 575–580.
Craddock, N, Dave, S, Greening, J (2001). Association studies of bipolar disorder. Bipolar Disorder 3, 284–298.
Craddock, N, O'Donovan, MC, Owen, MJ (2006). Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophrenia Bulletin 32, 9–16.
Crowley, JJ, Keefe, RS, Perkins, DO, Stroup, TS, Lieberman, JA, Sullivan, PF (2008). The neuregulin 1 promoter polymorphism rs6994992 is not associated with chronic schizophrenia or neurocognition. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 147B, 1298–1300.
Dempster, E, Toulopoulou, T, McDonald, C, Bramon, E, Walshe, M, Filbey, F, Wickham, H, Sham, PC, Murray, RM, Collier, DA (2005). Association between BDNF val66 met genotype and episodic memory. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 134B, 73–75.
Durany, N, Michel, T, Zochling, R, Boissl, KW, Cruz-Sanchez, FF, Riederer, P, Thome, J (2001). Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophrenia Research 52, 79–86.
Dutt, A, McDonald, C, Dempster, E, Prata, D, Shaikh, M, Williams, I, Schulze, K, Marshall, N, Walshe, M, Allin, M, Collier, D, Murray, R, Bramon, E (2009). The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis. Psychological Medicine 39, 1783–1797.
Egan, MF, Goldberg, TE, Kolachana, BS, Callicott, JH, Mazzanti, CM, Straub, RE, Goldman, D, Weinberger, DR (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences USA 98, 6917–6922.
Egan, MF, Kojima, M, Callicott, JH, Goldberg, TE, Kolachana, BS, Bertolino, A, Zaitsev, E, Gold, B, Goldman, D, Dean, M, Lu, B, Weinberger, DR (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257–269.
Ehlis, AC, Reif, A, Herrmann, MJ, Lesch, KP, Fallgatter, AJ (2007). Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders. Neuropsychopharmacology 32, 162–170.
Endicott, J, Spitzer, RL (1978). A diagnostic interview: the schedule for affective-disorders and schizophrenia. Archives of General Psychiatry 35, 837–844.
Falls, DL (2003). Neuregulins: functions, forms, and signaling strategies. Experimental Cell Research 284, 14–30.
Fan, JB, Zhang, CS, Gu, NF, Li, XW, Sun, WW, Wang, HY, Feng, GY, St Clair, D, He, L (2005). Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biological Psychiatry 57, 139–44.
First, M, Spitzer, R, Gibbon, M, Williams, J (1997). Structured Clinical Interview for DSM-IV Axis I Disorders. American Psychiatric Press: Washington, DC.
Franks, R, Adler, L, Waldo, M, Alpert, J, Freedman, R (1983). Neurophysiological studies of sensory gating in mania: comparison with schizophrenia. Biological Psychiatry 18, 989–1005.
Freedman, R, Adler, L, Myles-Worsley, M, Nagamoto, H, Miller, C, Kisley, M, McRae, K, Cawthra, E, Waldo, M (1996). Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Archives of General Psychiatry 53, 1114–1121.
Freedman, R, Adler, L, Waldo, M, Pachtman, E, Franks, R (1983). Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. Biological Psychiatry 18, 537–551.
Freedman, R, Adler, LE, Gerhardt, GA, Waldo, M, Baker, N, Rose, GM, Drebing, C, Nagamoto, H, Bickfordwimer, P, Franks, R (1987). Neurobiological studies of sensory gating in schizophrenia. Schizophrenia Bulletin 13, 669–678.
Freedman, R, Coon, H, Myles-Worsley, M, Orr-Urtreger, A, Olincy, A, Davis, A, Polymeropoulos, M, Holik, J, Hopkins, J, Hoff, M, Rosenthal, J, Waldo, MC, Reimherr, F, Wender, P, Yaw, J, Young, D, Breese, CR, Adams, C, Patterson, D, Adler, LE, Kruglyak, L, Leonard, S, Byerley, W (1997). Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proceedings of the National Academy of Sciences USA 94, 587–592.
Gail, MH, Pee, D, Carroll, R (2001). Effects of violations of assumptions on likelihood methods for estimating the penetrance of an autosomal dominant mutation from kin-cohort studies. Journal of Statistical Planning and Inference 96, 167–177.
Gallinat, J, Bajbouj, M, Sander, T, Schlattmann, P, Xu, K, Ferro, EF, Goldman, D, Winterer, G (2003). Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biological Psychiatry 54, 40–48.
Gauderman, WJ (2002). Sample size requirements for association studies of gene-gene interaction. American Journal of Epidemiology 155, 478–484.
Georgieva, L, Dimitrova, A, Ivanov, D, Nikolov, I, Williams, NM, Grozeva, D, Zaharieva, I, Toncheva, D, Owen, MJ, Kirov, G, O'Donovan, MC (2008). Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. Biological Psychiatry 64, 419–427.
Glatt, SJ, Faraone, SV, Tsuang, MT (2003). Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. American Journal of Psychiatry 160, 469–476.
Goghari, VM, Sponheim, SR (2008). Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder. Schizophrenia Research 103, 186–191.
Golimbet, V, Gritsenko, I, Alfimova, M, Lebedeva, I, Lezheiko, T, Abramova, L, Kaleda, V, Ebstein, R (2006). Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives. World Journal of Biological Psychiatry 7, 238–245.
Golimbet, VE, Lebedeva, IS, Korovaitseva, GI, Lezheiko, TV, Yumatova, PE (2008). Association of 5-HTTLPR serotonin transporter gene polymorphism and Val66Met brain-derived neurotrophic factor gene polymorphism with auditory N100 evoked potential amplitude in patients with endogenous psychoses. Bulletin of Experimental Biology and Medicine 146, 605–608.
Gong, YG, Wu, CN, Xing, QH, Zhao, XZ, Zhu, J, He, L (2009). A two-method meta-analysis of Neuregulin 1(NRG1) association and heterogeneity in schizophrenia. Schizophrenia Research 111, 109–114.
Gottesman, II, Gould, TD (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry 160, 636–645.
Gratacos, M, Gonzalez, JR, Mercader, JM, de Cid, R, Urretavizcaya, M, Estivill, X (2007). Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biological Psychiatry 61, 911–922.
Green, EK, Raybould, R, Macgregor, S, Gordon-Smith, K, Heron, J, Hyde, S, Grozeva, D, Hamshere, M, Williams, N, Owen, MJ, O'Donovan, MC, Jones, L, Jones, I, Kirov, G, Craddock, N (2005). Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Archives of General Psychiatry 62, 642–668.
Grunwald, T, Boutros, NN, Pezer, N, von Oertzen, J, Fernandez, G, Schaller, C, Elger, CE (2003). Neuronal substrates of sensory gating within the human brain. Biological Psychiatry 53, 511–519.
Hall, J, Whalley, HC, Job, DE, Baig, BJ, McIntosh, AM, Evans, KL, Thomson, PA, Porteous, DJ, Cunningham-Owens, DG, Johnstone, EC, Lawrie, SM (2006 a). A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nature Neuroscience 9, 1477–1478.
Hall, MH, Schulze, K, Rijsdijk, F, Picchioni, M, Ettinger, U, Bramon, E, Freedman, R, Murray, RM, Sham, P (2006 b). Heritability and reliability of P300, P50 and duration mismatch negativity. Behavior Genetics 36, 845–857.
Hall, MH, Schulze, K, Sham, P, Kalidindi, S, McDonald, C, Bramon, E, Levy, DL, Murray, RM, Rijsdijk, F (2008). Further evidence for shared genetic effects between psychotic bipolar disorder and P50 suppression: a combined twin and family study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 147B, 619–627.
Han, DH, Park, DB, Choi, TY, Joo, SY, Lee, MK, Park, BR, Nishimura, R, Chu, CC, Renshaw, PF (2008). Effects of brain-derived neurotrophic factor-catecholamine-O-methyltransferase gene interaction on schizophrenic symptoms. Neuroreport 19, 1155–1158.
Handoko, HY, Nyholt, DR, Hayward, NK, Nertney, DA, Hannah, DE, Windus, LC, McCormack, CM, Smith, HJ, Filippich, C, James, MR, Mowry, BJ (2005). Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Molecular Psychiatry 10, 589–597.
Hariri, AR, Goldberg, TE, Mattay, VS, Kolachana, BS, Callicott, JH, Egan, MF, Weinberger, DR (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience 23, 6690–6694.
Harrison, PJ, Weinberger, DR (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 10, 40–68; image 5.
Hong, CJ, Yu, YW, Lin, CH, Tsai, SJ (2003). An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neuroscience Letters 349, 206–208.
Ikeda, M, Takahashi, N, Saito, S, Aleksic, B, Watanabe, Y, Nunokawa, A, Yamanouchi, Y, Kitajima, T, Kinoshita, Y, Kishi, T, Kawashima, K, Hashimoto, R, Ujike, H, Inada, T, Someya, T, Takeda, M, Ozaki, N, Iwata, N (2008). Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample. Schizophrenia Research 101, 1–8.
Jonsson, EG, Edman-Ahlbom, B, Sillen, A, Gunnar, A, Kulle, B, Frigessi, A, Vares, M, Ekholm, B, Wode-Helgodt, B, Schumacher, J, Cichon, S, Agartz, I, Sedvall, GC, Hall, H, Terenius, L (2006). Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Progress in Neuropsychopharmacology and Biological Psychiatry 30, 924–933.
Jonsson, EG, Saetre, P, Vares, M, Andreou, D, Larsson, K, Timm, S, Rasmussen, HB, Djurovic, S, Melle, I, Andreassen, OA, Agartz, I, Werge, T, Hall, H, Terenius, L (2009). DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study. Neuropsychobiology 59, 142–150.
Judd, LL, McAdams, L, Budnick, B, Braff, DL (1992). Sensory gating deficits in schizophrenia: new results. American Journal of Psychiatry 149, 488–493.
Kanazawa, T, Glatt, SJ, Kia-Keating, B, Yoneda, H, Tsuang, MT (2007). Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatric Genetics 17, 165–170.
Kawashima, K, Ikeda, M, Kishi, T, Kitajima, T, Yamanouchi, Y, Kinoshita, Y, Okochi, T, Aleksic, B, Tomita, M, Okada, T, Kunugi, H, Inada, T, Ozaki, N, Iwata, N (2009). BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis. Schizophrenia Research 112, 72–79.
Kirov, G, Jones, I, McCandless, F, Craddock, N, Owen, MJ (1999). Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5. Molecular Psychiatry 4, 558–565.
Kirov, G, Zaharieva, I, Georgieva, L, Moskvina, V, Nikolov, I, Cichon, S, Hillmer, A, Toncheva, D, Owen, MJ, O'Donovan, MC (2009). A genome-wide association study in 574 schizophrenia trios using DNA pooling. Molecular Psychiatry 14, 796–803.
Knight, RT, Staines, WR, Swick, D, Chao, LL (1999). Prefrontal cortex regulates inhibition and excitation in distributed neural networks. Acta Psychologica 101, 159–178.
Lewis, CM, Levinson, DF, Wise, LH, DeLisi, LE, Straub, RE, Hovatta, I, Williams, NM, Schwab, SG, Pulver, AE, Faraone, SV, Brzustowicz, LM, Kaufmann, CA, Garver, DL, Gurling, HM, Lindholm, E, Coon, H, Moises, HW, Byerley, W, Shaw, SH, Mesen, A, Sherrington, R, O'Neill, FA, Walsh, D, Kendler, KS, Ekelund, J, Paunio, T, Lonnqvist, J, Peltonen, L, O'Donovan, MC, Owen, MJ, Wildenauer, DB, Maier, W, Nestadt, G, Blouin, JL, Antonarakis, SE, Mowry, BJ, Silverman, JM, Crowe, RR, Cloninger, CR, Tsuang, MT, Malaspina, D, Harkavy-Friedman, JM, Svrakic, DM, Bassett, AS, Holcomb, J, Kalsi, G, McQuillin, A, Brynjolfson, J, Sigmundsson, T, Petursson, H, Jazin, E, Zoëga, T, Helgason, T (2003). Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. American Journal of Human Genetics 73, 34–48.
Li, D, Collier, DA, He, L (2006). Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Human Molecular Genetics 15, 1995–2002.
Li, T, Ball, D, Zhao, J, Murray, RM, Liu, X, Sham, PC, Collier, DA (2000). Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Molecular Psychiatry 5, 452.
Li, T, Sham, PC, Vallada, H, Xie, T, Tang, X, Murray, RM, Liu, X, Collier, DA (1996). Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatric Genetics 6, 131–133.
Light, GA, Malaspina, D, Geyer, MA, Luber, BM, Coleman, EA, Sackeim, HA, Braff, DL (1999). Amphetamine disrupts P50 suppression in normal subjects. Biological Psychiatry 46, 990–996.
Lohmueller, KE, Pearce, CL, Pike, M, Lander, ES, Hirschhorn, JN (2003). Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nature Genetics 33, 177–182.
Lohoff, FW, Sander, T, Ferraro, TN, Dahl, JP, Gallinat, J, Berrettini, WH (2005). Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 139B, 51–53.
Louchart-de la Chapelle, S, Nkam, I, Houy, E, Belmont, A, Menard, JF, Roussignol, AC, Siwek, O, Mezerai, M, Guillermou, M, Fouldrin, G, Levillain, D, Dollfus, S, Campion, D, Thibaut, F (2005). A concordance study of three electrophysiological measures in schizophrenia. American Journal of Psychiatry 162, 466–474.
Lu, BY, Martin, KE, Edgar, JC, Smith, AK, Lewis, SF, Escamilla, MA, Miller, GA, Canive, JM (2007). Effect of catechol O-methyltransferase val(158)met polymorphism on the p50 gating endophenotype in schizophrenia. Biological Psychiatry 62, 822–825.
Maxwell, M (1992). Family Interview for Genetic Studies. Clinical Neurogenetics Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD.
Meyer-Lindenberg, A, Weinberger, DR (2006). Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews. Neuroscience 7, 818–827.
Munafo, MR, Attwood, AS, Flint, J (2008). Neuregulin 1 genotype and schizophrenia. Schizophrenia Bulletin 34, 9–12.
Munafo, MR, Bowes, L, Clark, TG, Flint, J (2005). Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Molecular Psychiatry 10, 765–770.
Mynett-Johnson, LA, Murphy, VE, Claffey, E, Shields, DC, McKeon, P (1998). Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatric Genetics 8, 221–225.
Nagamoto, HT, Adler, LE, Waldo, MC, Freedman, R (1989). Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval. Biological Psychiatry 25, 549–561.
Neves-Pereira, M, Cheung, JK, Pasdar, A, Zhang, F, Breen, G, Yates, P, Sinclair, M, Crombie, C, Walker, N, St Clair, DM (2005). BDNF gene is a risk factor for schizophrenia in a Scottish population. Molecular Psychiatry 10, 208–212.
Neves-Pereira, M, Mundo, E, Muglia, P, King, N, Macciardi, F, Kennedy, JL (2002). The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. American Journal of Human Genetics 71, 651–655.
Norton, N, Williams, HJ, Owen, MJ (2006). An update on the genetics of schizophrenia. Current Opinion in Psychiatry 19, 158–164.
Numata, S, Ueno, S, Iga, J, Yamauchi, K, Hongwei, S, Ohta, K, Kinouchi, S, Shibuya-Tayoshi, S, Tayoshi, S, Aono, M, Kameoka, N, Sumitani, S, Tomotake, M, Kaneda, Y, Taniguchi, T, Ishimoto, Y, Ohmori, T (2006). Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neuroscience Letters 401, 1–5.
Okochi, T, Ikeda, M, Kishi, T, Kawashima, K, Kinoshita, Y, Kitajima, T, Yamanouchi, Y, Tomita, M, Inada, T, Ozaki, N, Iwata, N (2009). Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophrenia Research 110, 140–148.
Olincy, A, Martin, L (2005). Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis. American Journal of Psychiatry 162, 43–49.
Olincy, A, Ross, R, Harris, J, Young, D, McAndrews, M, Cawthra, E, McRae, K, Sullivan, B, Adler, L, Freedman, R (2000). The P50 auditory event-evoked potential in adult attention-deficit disorder: comparison with schizophrenia. Biological Psychiatry 47, 969–977.
Owen, MJ, Craddock, N, Jablensky, A (2007). The genetic deconstruction of psychosis. Schizophrenia Bulletin 33, 905–911.
Owen, MJ, Craddock, N, O'Donovan, MC (2005). Schizophrenia: genes at last? Trends in Genetics 21, 518–525.
Owen, MJ, Williams, NM, O'Donovan, MC (2004). The molecular genetics of schizophrenia: new findings promise new insights. Molecular Psychiatry 9, 14–27.
Pezawas, L, Verchinski, BA, Mattay, VS, Callicott, JH, Kolachana, BS, Straub, RE, Egan, MF, Meyer-Lindenberg, A, Weinberger, DR (2004). The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. Journal of Neuroscience 24, 10099–10102.
Poo, MM (2001). Neurotrophins as synaptic modulators. Nature Reviews. Neuroscience 2, 24–32.
Prata, DP, Breen, G, Munro, J, Sinclair, M, Osborne, S, Li, T, Kerwin, R, St Clair, D, Collier, DA (2006). Bipolar 1 disorder is not associated with the RGS4, PRODH, COMT and GRK3 genes. Psychiatric Genetics 16, 229–230.
Prata, DP, Breen, G, Osborne, S, Munro, J, St Clair, D, Collier, DA (2009). An association study of the neuregulin 1 gene, bipolar affective disorder and psychosis. Psychiatric Genetics 19, 113–116.
Qian, L, Zhao, J, Shi, Y, Zhao, X, Feng, G, Xu, F, Zhu, S, He, L (2007). Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis. Biochemical and Biophysical Research Communications 353, 738–743.
Riley, B, Kendler, KS (2006). Molecular genetic studies of schizophrenia. European Journal of Human Genetics 14, 669–680.
Rosa, A, Cuesta, MJ, Fatjo-Vilas, M, Peralta, V, Zarzuela, A, Fananas, L (2006). The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 141B, 135–138.
Sanchez-Morla, EM, Garcia-Jimenez, MA, Barabash, A, Martinez-Vizcaino, V, Mena, J, Cabranes-Diaz, JA, Baca-Baldomero, E, Santos, JL (2008). P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia. Acta Psychiatrica Scandinavica 117, 313–318.
Sand, PG, Eichhammer, P, Langguth, B, Hajak, G (2006). COMT association data in schizophrenia: new caveats. Biological Psychiatry 60, 663–664; author reply 664–665.
Sanders, AR, Duan, J, Levinson, DF, Shi, J, He, D, Hou, C, Burrell, GJ, Rice, JP, Nertney, DA, Olincy, A, Rozic, P, Vinogradov, S, Buccola, NG, Mowry, BJ, Freedman, R, Amin, F, Black, DW, Silverman, JM, Byerley, WF, Crowe, RR, Cloninger, CR, Martinez, M, Gejman, PV (2008). No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. American Journal of Psychiatry 165, 497–506.
Schulze, KK, Hall, MH, McDonald, C, Marshall, N, Walshe, M, Murray, RM, Bramon, E (2007). P50 auditory evoked potential suppression in bipolar disorder patients with psychotic features and their unaffected relatives. Biological Psychiatry 62, 121–128.
Serretti, A, Cusin, C, Cristina, S, Lorenzi, C, Lilli, R, Lattuada, E, Grieco, G, Costa, A, Santorelli, F, Barale, F, Smeraldi, E, Nappi, G (2003). Multicentre Italian family-based association study on tyrosine hydroxylase, catechol-O-methyl transferase and Wolfram syndrome 1 polymorphisms in mood disorders. Psychiatric Genetics 13, 121–126.
Shifman, S, Bronstein, M, Sternfeld, M, Pisanté, A, Weizman, A, Reznik, I, Spivak, B, Grisaru, N, Karp, L, Schiffer, R, Kotler, M, Strous, RD, Swartz-Vanetik, M, Knobler, HY, Shinar, E, Yakir, B, Zak, NB, Darvasi, A (2004). COMT: a common susceptibility gene in bipolar disorder and schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 128B, 61–64.
Shifman, S, Bronstein, M, Sternfeld, M, Pisanté-Shalom, A, Lev-Lehman, E, Weizman, A, Reznik, I, Spivak, B, Grisaru, N, Karp, L, Schiffer, R, Kotler, M, Strous, RD, Swartz-Vanetik, M, Knobler, HY, Shinar, E, Beckmann, JS, Yakir, B, Risch, N, Zak, NB, Darvasi, A (2002). A highly significant association between a COMT haplotype and schizophrenia. American Journal of Human Genetics 71, 1296–1302.
Siegel, C, Waldo, M, Mizner, G, Adler, L, Freedman, R (1984). Deficits in sensory gating in schizophrenic patients and their relatives. Archives of General Psychiatry 41, 607–612.
Sklar, P, Gabriel, SB, McInnis, MG, Bennett, P, Lim, YM, Tsan, G, Schaffner, S, Kirov, G, Jones, I, Owen, M, Craddock, N, DePaulo, JR, Lander, ES (2002). Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Molecular Psychiatry 7, 579–593.
Sklar, P, Smoller, JW, Fan, J, Ferreira, MA, Perlis, RH, Chambert, K, Nimgaonkar, VL, McQueen, MB, Faraone, SV, Kirby, A, de Bakker, PI, Ogdie, MN, Thase, ME, Sachs, GS, Todd-Brown, K, Gabriel, SB, Sougnez, C, Gates, C, Blumenstiel, B, Defelice, M, Ardlie, KG, Franklin, J, Muir, WJ, McGhee, KA, MacIntyre, DJ, McLean, A, VanBeck, M, McQuillin, A, Bass, NJ, Robinson, M, Lawrence, J, Anjorin, A, Curtis, D, Scolnick, EM, Daly, MJ, Blackwood, DH, Gurling, HM, Purcell, SM (2008). Whole-genome association study of bipolar disorder. Molecular Psychiatry 13, 558–569.
Smith, DA, Boutros, NN, Schwarzkopf, SB (1994). Reliability of P50 auditory event-related potential indexes of sensory gating. Psychophysiology 31, 495–502.
Stefansson, H, Sarginson, J, Kong, A, Yates, P, Steinthorsdottir, V, Gudfinnsson, E, Gunnarsdottir, S, Walker, N, Petursson, H, Crombie, C, Ingason, A, Gulcher, JR, Stefansson, K, St Clair, D (2003). Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. American Journal of Human Genetics 72, 83–87.
Stefansson, H, Sigurdsson, E, Steinthorsdottir, V, Bjornsdottir, S, Sigmundsson, T, Ghosh, S, Brynjolfsson, J, Gunnarsdottir, S, Ivarsson, O, Chou, TT, Hjaltason, O, Birgisdottir, B, Jonsson, H, Gudnadottir, VG, Gudmundsdottir, E, Bjornsson, A, Ingvarsson, B, Ingason, A, Sigfusson, S, Hardardottir, H, Harvey, RP, Lai, D, Zhou, M, Brunner, D, Mutel, V, Gonzalo, A, Lemke, G, Sainz, J, Johannesson, G, Andresson, T, Gudbjartsson, D, Manolescu, A, Frigge, ML, Gurney, ME, Kong, A, Gulcher, JR, Petursson, H, Stefansson, K (2002). Neuregulin 1 and susceptibility to schizophrenia. American Journal of Human Genetics 71, 877–892.
Stefansson, H, Steinthorsdottir, V, Thorgeirsson, TE, Gulcher, JR, Stefansson, K (2004). Neuregulin 1 and schizophrenia. Annals of Medicine 36, 62–71.
Stevens, KE, Freedman, R, Collins, AC, Hall, M, Leonard, S, Marks, MJ, Rose, GM (1996). Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology 15, 152–162.
Szeszko, PR, Lipsky, R, Mentschel, C, Robinson, D, Gunduz-Bruce, H, Sevy, S, Ashtari, M, Napolitano, B, Bilder, RM, Kane, JM, Goldman, D, Malhotra, AK (2005). Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Molecular Psychiatry 10, 631–636.
Takahashi, M, Shirakawa, O, Toyooka, K, Kitamura, N, Hashimoto, T, Maeda, K, Koizumi, S, Wakabayashi, K, Takahashi, H, Someya, T, Nawa, H (2000). Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Molecular Psychiatry 5, 293–300.
Tosato, S, Dazzan, P, Collier, D (2005). Association between the neuregulin 1 gene and schizophrenia: a systematic review. Schizophrenia Bulletin 31, 613–617.
Tsai, SJ, Yu, YWY, Chen, TJ, Chen, JY, Liou, YJ, Chen, MC, Hong, CJ (2003). Association study of a functional catechol-O-methyltransferase gene polymorphism and cognitive function in healthy females. Neuroscience Letters 338, 123–126.
Venables, P (1964). Input dysfunction in schizophrenia. In Progress in Experimental Personality Research ( ed. Maher, B. A.), pp. 1–47. Academic Press: New York.
Waldo, M, Cawthra, E, Adler, L, Dubester, S, Staunton, M, Nagamoto, H, Baker, N, Madison, A, Simon, J, Scherzinger, A, Drebing, C, Gerhardt, G, Freedman, R (1994). Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings. Schizophrenia Research 12, 93–106.
Waldo, M, Myles-Worsley, M, Madison, A, Byerley, W, Freedman, R (1995). Sensory gating deficits in parents of schizophrenics. American Journal of Medical Genetics 60, 506–511.
Waldo, MC, Adler, LE, Freedman, R (1988). Defects in auditory sensory gating and their apparent compensation in relatives of schizophrenics. Schizophrenia Research 1, 19–24.
Waldo, MC, Adler, LE, Leonard, S, Olincy, A, Ross, RG, Harris, JG, Freedman, R (2000). Familial transmission of risk factors in the first-degree relatives of schizophrenic people. Biological Psychiatry 47, 231–239.
Waldo, MC, Carey, G, Myles-Worsley, M, Cawthra, E, Adler, LE, Nagamato, HT, Wender, P, Byerley, W, Plaetke, R, Freedman, R (1991). Codistribution of a sensory gating deficit and schizophrenia in multi-affected families. Psychiatry Research 39, 257–284.
Ward, PB, Hoffer, LD, Leibert, B, Catts, SV, O'Donnell, M, Adler, LE (1996). Replication of a P50 auditory gating deficit in Australian patients with schizophrenia. Psychiatry Research 64, 121–135.
Weickert, CS, Hyde, TM, Lipska, BK, Herman, MM, Weinberger, DR, Kleinman, JE (2003). Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Molecular Psychiatry 8, 592–610.
Williams, NM, Preece, A, Spurlock, G, Norton, N, Williams, HJ, Zammit, S, O'Donovan, MC, Owen, MJ (2003). Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Molecular Psychiatry 8, 485–487.
Winterer, G, Weinberger, DR (2004). Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends in Neuroscience 27, 683–690.
Xu, MQ, St Clair, D, Ott, J, Feng, GY, He, L (2007). Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophrenia Research 91, 6–13.
Yamada, K, Nabeshima, T (2003). Brain-derived neurotrophic factor/TrkB signaling in memory processes. Journal of Pharmacological Sciences 91, 267–270.
Young, D, Waldo, M, Rutledge, JH, Freedman, R (1996). Heritability of inhibitory gating of the P50 auditory-evoked potential in monozygotic and dizygotic twins. Biological Psychiatry 33, 113–117.
Yue, C, Wu, T, Deng, W, Wang, G, Sun, X (2009). Comparison of visual evoked-related potentials in healthy young adults of different catechol-O-methyltransferase genotypes in a continuous 3-back task. Neuroreport 20, 521–524.
Zhang, Z, Lindpaintner, K, Che, R, He, Z, Wang, P, Yang, P, Feng, G, He, L, Shi, Y (2009). The Val/Met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a meta-analysis. Journal of Neural Transmission 116, 1193–1200.
Zintzaras, E (2007). Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis. Psychiatric Genetics 17, 69–75.